Charlotte S. Walmsley

Beth Israel Deaconess Medical Center — United States

Medicine · Health Sciences

12h-index1.2kcitations62works6.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(14), Advanced Breast Cancer Therapies(10), Brain Metastases and Treatment(9), Fibroblast Growth Factor Research(9), Cancer Genomics and Diagnostics(8)

Publications62 total

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
Journal of Clinical Oncology·2025· 3 cited
Civil War as Fratricidal Conflict? Re-examining the Case of Violence against Women in Liberation France
World histories of crime, culture and violence·2025
Histopathological Analysis of Abdominal Skin and Fat After In Vivo Hyperthermia-Induced Lipolysis With a 1064 nm Diode Laser, Radiofrequency, and Electromagnetic Field: A Pilot Study
Aesthetic Surgery Journal Open Forum·2024· 1 citedOpen Access
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
Annals of Oncology·2024· 26 cited
Hemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitor use: A review of the current knowledge and future directions
Blood Cells Molecules and Diseases·2024· 13 citedOpen Access
320P Effect of clinical trial eligibility criteria on patient selection for advanced biliary tract cancers
Annals of Oncology·2024Open Access
CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature
Journal of the National Comprehensive Cancer Network·2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy
npj Precision Oncology·2024· 12 citedOpen Access
Data from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Table from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Table from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Figure from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Figure from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Table from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Data from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Table from EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma
2023Open Access
Supplementary Figures from Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers
2023Open Access
Supplementary Table S8 (xlsx) from Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers
2023Open Access
Data from Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer
2023Open Access
Supplementary Table S10 (xlsx) from Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Dejan Juric(34), Aditya Bardia(22), James R. Stone(15), Christopher J. Pinto(13), Rémi Klotz(11), Amal Thomas(11), Oihana Iriondo(11), Sara Restrepo-Vassalli(11), Alan Wang(11), Negeen Izadian(11), Matthew MacKay(11), Byoung-San Moon(11), Kevin J. Liu(11), Sathish Kumar Ganesan(11), Diane S. Kang(11), Michael F. Press(11), Wange Lu(11), Janice Lu(11), James Hicks(11), Bodour Salhia(11)